A scheme to manipulate bank regulations governing stock conversions has ended in a guilty plea for one former executive of Wall Street firm Oppenheimer & Co.
Sanofi-Aventis has filed a patent suit over Ambien CR, marking at least the second time since February the French pharmaceutical giant has attempted to keep a generic competitor out of the multibillion-dollar market for the insomnia drug.
Abbott Laboratories has filed a lawsuit against an Indian pharmaceutical company and its U.S. subsidiary in a move to stave off efforts to horn in on the billion-dollar U.S. market for the drug Depakote.
Claims by a group of sacked Hoffman-La Roche employees that the drug maker outsourced their jobs to avoid future pension payments have been dismissed by an appeals court on a technicality.
Delivering another blow to Congoleum Corp., a bankruptcy judge has denied the flooring manufacturer’s request for approval of a $25 million settlement with a band of its insurers, unconvinced that it would be a good deal for creditors.
Hess Corp. has violated federal law and exposed customers to potential identity theft by including too much information on receipts issued to customers who buy gas with credit cards at Hess’ filling stations, according to a proposed class action filed Friday.
Insurance company Geico has filed its defense against a growing number of wage-and-hour suits by auto claims adjusters, arguing the employees were exempt from overtime wages under federal law.
California Attorney General Jerry Brown has warned that the federal government may have to shell out billions of dollars to save the U.S. auto industry from going under, saying the government has enabled the industry to waste enormous amounts of gas through inadequate federal fuel efficiency standards.
Five major U.S.-based railroad freight haulers on Monday were hit with a proposed class action accusing them of conspiring to fix prices of rail fuel surcharges for unregulated private freight transport for over three years.
In a win for Johnson & Johnson, a U.S. appeals court has upheld a ban on the sale of a cheap version of the pharmaceutical giant’s antipsychotic drug Risperdal for the life of its key patent.
SGL Carbon suffered a setback on Thursday, with the European Union’s highest court tossing the German carbon and graphite maker’s appeal of a lower court’s decision to slash a €27.75 million fine levied for price-fixing charges to €18.45 million, a penalty the company argued should have been reduced even further.
The U.S. Securities and Exchange Commission is reportedly investigating claims made in Fairfax Financial Holdings’ $5 billion lawsuit against a slew of hedge funds accused of disparaging the company as part of a short-selling scam.
Though Congressmen agree that there are problems with the subprime mortgage industry, they have different ideas about how to tackle them, as evidenced by the debate at Wednesday’s meeting of the House Subcommittee on Financial Services.
Brazil’s president has signed a compulsory license that overrides Merck & Co. Inc.’s patent on HIV/AIDS drug Efavirenz so that the country can import a generic version of the drug from India.
A district court has certified the class in a breach of contract suit filed by employees of Caesars’ Palace, who allege that the company did not pay them for the full value of their stock options after being acquired by rival casino owner Harrah’s.
Mylan Pharmaceuticals Inc. has moved closer to regulatory approval to make generic Femara, the drug maker said Thursday, raising the stakes in a patent infringement suit Germany’s Novartis AG filed to protect the popular breast cancer treatment.
An appellate court on Tuesday affirmed a district court’s decision to dismiss a long-standing ERISA case brought against AT&T Corp., Lucent Technologies Inc. and Texas Pacific Group, three years after the same court reversed summary judgment and remanded in the same suit.
A Canadian appeals court has upheld patents for painkiller Celebrex that prevent the launch of a generic version of the drug until November 2014, Pfizer Inc. said Tuesday.
An appellate court on Thursday affirmed a lower court’s findings that two patents for ultraviolet light water purification were invalid because the patents’ claims were anticipated by prior art.
A judge on Friday dissolved the civil contempt that has kept former financier Martin A. Armstrong incarcerated for the past seven years, ruling that Armstrong’s continued confinement had no prospect of compelling compliance with the court order that sent him to jail in January 2000.